Frequency of migraine with or without aura may be correlated with symptoms of anxiety and depression.
Patients previously diagnosed with depression or anxiety did not have a greater risk of Alzheimer's.
Prescriptions for benzodiazepine lasting 2-3 months or more and marked dose increases should be avoided.
A study aimed to clarify the relationship between anxiety and depression in patients with multiple sclerosis.
Interventions with clinical massage or guided imagery may help ease pain and anxiety in patients in a progressive care unit.
Comorbid psychological conditions affect cognitive function in Parkinson's disease, and treatment can be complicated by overlapping symptoms.
Varenicline and bupropion pose a lower risk of serious mental health side effects than was previously thought.
Number of AEDs and seizure frequency also influenced depression in people with epilepsy.
Patients with tension-type headaches had a significantly higher prevalence of anxiety and depression.
There has been a lack of research on the association between anxiety and dementia.
Participants in the yoga/meditation group also showed reduced levels of depression and anxiety.
The psychological consequences of stroke appear to influence outcomes.
Anxiety appeared to affect both verbal and visual memory.
Researchers have uncovered a positive synergistic interaction between Alzheimer's pathology and neuropsychiatric symptoms.
Physical comorbidities are mediated by depression in MS.
The overdose death rate leveled out after 2010.
Associations were mainly significant for 16 mental disorders, including anxiety and substance abuse.
Incorporating mental health screenings in epilepsy appointments may help prevent suicides.
Veterans randomized to mindfulness-based stress reduction reported greater reductions in pain, fatigue, and memory/concentration problems.
Remote counseling may not be suitable for patients with more severe illness.
Researchers saw a reduction in post-op pain, anxiety, and analgesia use in patients under general anesthesia.
The high prevalence of pain in MS patients affects treatment plans.
In chronic pain patients, increased activation of microglia can cause depression and anxiety.
The therapy did seem to improve symptoms of depression and anxiety in some women.
Most of the increase has been among patients who have less serious illness.
When playing with guinea pigs, skin conductance, a measure of anxiety, started to decline.
The effects of binge drinking in adolescence last throughout adulthood, according to results from a study in rats.
While symptoms improved equally in both groups, patients that received a second SGB injection saw even greater improvement.
Air pollutants from fossil fuels and industrial sources can take a toll on both mental and physical health.
The findings could have implications for treatment and prevention of alcohol addiction disorders.
Neurology Advisor Articles
- Clarifying Cardiovascular Risk in Migraine
- Parkinson Disease Symptom Fluctuations Well-Managed With Adaptive Deep Brain Stimulation
- More Evidence Supports Benefits of Cannabidiol for Treatment-Resistant Epilepsy
- Monthly Erenumab Reduces Frequency of Episodic Migraine
- Reduced Risk for Multiple Sclerosis Linked to Greater Sun Exposure
- Tamsulosin Associated With Dementia Risk in Older Patients With BPH
- FDA Approves Blood Test to Assess Concussion
- Gait Difficulty in Parkinson Disease May Be Associated With More Progressive Disease Course
- Tau PET a Useful Biomarker for Alzheimer Disease Risk and Progression
- Multiple Sclerosis Drug Zinbryta Withdrawn From the Market
- Incidence of Delayed Traumatic Intracranial Hemorrhage Low in Older Adults With Blunt Head Trauma
- Older Epilepsy Patients More Likely to Experience AED, Non-AED Drug Interaction
- Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS
- Accelerated Cognitive Decline Associated With Retinopathy
- Treatment Effects Often Exaggerated in Early Clinical Studies